1	Endosialin/TEM	Endosialin/TEM	B-NP	NN	B-protein	2	NMOD	-1
2	1/CD248	1/CD248	I-NP	NN	I-protein	3	SUB	-1
3	is	be	B-VP	VBZ	O	0	ROOT	-1
4	a	a	B-NP	DT	O	6	NMOD	-1
5	pericyte	pericyte	I-NP	NN	O	6	NMOD	-1
6	marker	marker	I-NP	NN	O	3	PRD	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	embryonic	embryonic	B-NP	JJ	O	11	NMOD	-1
9	and	and	I-NP	CC	O	11	NMOD	-1
10	tumor	tumor	I-NP	NN	O	11	NMOD	-1
11	neovascularization	neovascularization	I-NP	NN	O	7	PMOD	3	neovascularization
12	.	.	O	.	O	3	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	formation	formation	I-NP	NN	O	9	SUB	2	formation
3	of	of	B-PP	IN	O	2	NMOD	-1
4	functional	functional	B-NP	JJ	O	6	AMOD	-1
5	,	,	I-NP	,	O	6	P	-1
6	mature	mature	I-NP	JJ	O	8	NMOD	-1
7	blood	blood	I-NP	NN	O	8	NMOD	-1
8	vessels	vessel	I-NP	NNS	O	3	PMOD	-1
9	depends	depend	B-VP	VBZ	O	0	ROOT	17	depends
10	on	on	B-PP	IN	O	9	VMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	interaction	interaction	I-NP	NN	O	10	PMOD	15	interaction
13	between	between	B-PP	IN	O	12	NMOD	-1
14	endothelial	endothelial	B-NP	JJ	B-cell_type	15	NMOD	-1
15	cells	cell	I-NP	NNS	I-cell_type	17	NMOD	-1
16	and	and	O	CC	O	17	NMOD	-1
17	pericytes	pericyte	B-NP	NNS	B-cell_type	13	PMOD	-1
18	.	.	O	.	O	9	P	-1

1	Commonality	Commonality	B-NP	NNP	O	2	SUB	-1
2	exists	exist	B-VP	VBZ	O	0	ROOT	-1
3	in	in	B-PP	IN	O	2	VMOD	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	processes	process	I-NP	NNS	O	3	PMOD	-1
6	involved	involve	B-VP	VBN	O	5	NMOD	0
7	in	in	B-PP	IN	O	6	VMOD	-1
8	vasculature	vasculature	B-NP	JJ	O	9	NMOD	-1
9	development	development	I-NP	NN	O	7	PMOD	2	development
10	between	between	B-PP	IN	O	9	NMOD	-1
11	tissues	tissue	B-NP	NNS	O	10	PMOD	-1
12	whether	whether	B-SBAR	IN	O	2	VMOD	-1
13	healthy	healthy	B-ADJP	JJ	O	15	AMOD	-1
14	or	or	I-ADJP	CC	O	15	AMOD	-1
15	diseased	diseased	I-ADJP	JJ	O	12	SBAR	-1
16	.	.	O	.	O	2	P	-1

1	Endosialin/TEM	Endosialin/TEM	B-NP	NN	O	3	SUB	-1
2	1	1	I-NP	CD	O	1	NMOD	-1
3	is	be	B-VP	VBZ	O	0	ROOT	-1
4	a	a	B-NP	DT	O	7	NMOD	-1
5	cell	cell	I-NP	NN	B-protein	7	NMOD	-1
6	membrane	membrane	I-NP	NN	I-protein	7	NMOD	-1
7	protein	protein	I-NP	NN	I-protein	3	PRD	-1
8	that	that	B-NP	WDT	O	7	NMOD	-1
9	is	be	B-VP	VBZ	O	8	SBAR	-1
10	expressed	express	I-VP	VBN	O	9	VC	9	expressed
11	in	in	B-PP	IN	O	10	VMOD	-1
12	blood	blood	B-NP	NN	O	13	NMOD	-1
13	vessels	vessel	I-NP	NNS	O	11	PMOD	-1
14	during	during	B-PP	IN	O	10	VMOD	-1
15	embryogenesis	embryogenesis	B-NP	NN	O	17	NMOD	-1
16	and	and	I-NP	CC	O	17	NMOD	-1
17	tumorigenesis	tumorigenesis	I-NP	NN	O	14	PMOD	-1
18	but	but	B-PP	CC	O	14	PMOD	-1
19	not	not	B-PP	RB	O	20	PMOD	-1
20	in	in	I-PP	IN	O	14	PMOD	-1
21	normal	normal	B-NP	JJ	O	23	NMOD	-1
22	mature	mature	I-NP	JJ	O	23	NMOD	-1
23	vessels	vessel	I-NP	NNS	O	20	PMOD	-1
24	.	.	O	.	O	3	P	-1

1	Antibodies	Antibody	B-NP	NNS	B-protein	2	SUB	-1
2	developed	develop	B-VP	VBD	O	0	ROOT	0
3	to	to	B-PP	TO	O	2	VMOD	-1
4	human	human	B-NP	JJ	B-protein	5	NMOD	-1
5	endosialin	endosialin	I-NP	NN	I-protein	3	PMOD	-1
6	were	be	B-VP	VBD	O	2	VMOD	-1
7	used	use	I-VP	VBN	O	6	VC	0
8	to	to	B-VP	TO	O	9	VMOD	-1
9	investigate	investigate	I-VP	VB	O	6	VMOD	-1
10	endosialin	endosialin	B-NP	NN	B-protein	11	NMOD	-1
11	expression	expression	B-NP	NN	O	13	NMOD	9	expression
12	and	and	O	CC	O	13	NMOD	-1
13	function	function	B-NP	NN	O	9	OBJ	-1
14	in	in	B-PP	IN	O	13	NMOD	-1
15	human	human	B-NP	JJ	B-cell_type	18	NMOD	-1
16	prenatal	prenatal	I-NP	JJ	I-cell_type	18	NMOD	-1
17	brain	brain	I-NP	NN	I-cell_type	18	NMOD	-1
18	pericytes	pericyte	I-NP	NNS	I-cell_type	20	NMOD	-1
19	and	and	I-NP	CC	O	20	NMOD	-1
20	pericytes	pericyte	I-NP	NNS	O	14	PMOD	-1
21	residing	reside	B-VP	VBG	O	20	NMOD	-1
22	in	in	B-PP	IN	O	21	VMOD	-1
23	tumors	tumor	B-NP	NNS	O	22	PMOD	-1
24	.	.	O	.	O	2	P	-1

1	Anti-endosialin	Anti-endosialin	B-NP	NNP	O	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	capable	capable	B-ADJP	JJ	O	2	PRD	-1
4	of	of	B-PP	IN	O	3	AMOD	-1
5	preventing	prevent	B-VP	VBG	O	4	PMOD	18	preventing
6	pericyte	pericyte	B-NP	NN	O	8	NMOD	-1
7	tube	tube	I-NP	NN	O	8	NMOD	-1
8	formation	formation	I-NP	NN	O	5	OBJ	2	formation
9	in	in	B-PP	IN	O	8	NMOD	-1
10	culture	culture	B-NP	NN	O	9	PMOD	0
11	and	and	O	CC	O	2	VMOD	-1
12	inhibited	inhibit	B-VP	VBD	O	2	VMOD	0
13	migration	migration	B-NP	NN	O	12	OBJ	0
14	.	.	O	.	O	2	P	-1

1	Brain	Brain	B-NP	NN	O	2	NMOD	-1
2	pericytes	pericyte	I-NP	NNS	O	5	SUB	-1
3	in	in	B-PP	IN	O	2	NMOD	-1
4	culture	culture	B-NP	NN	O	3	PMOD	0
5	had	have	B-VP	VBD	O	0	ROOT	-1
6	higher	high	B-NP	JJR	O	7	NMOD	-1
7	levels	level	I-NP	NNS	O	5	OBJ	-1
8	of	of	B-PP	IN	O	7	NMOD	-1
9	endosialin/TEM	endosialin/TEM	B-NP	NN	B-protein	8	PMOD	-1
10	1	1	I-NP	CD	I-protein	9	NMOD	-1
11	than	than	B-PP	IN	O	7	NMOD	-1
12	TEMs-2	TEMs-2	B-NP	NN	O	23	NMOD	-1
13	,	,	O	,	O	23	P	-1
14	-3	-3	B-NP	CD	O	23	NMOD	-1
15	,	,	I-NP	,	O	23	P	-1
16	-4	-4	I-NP	CD	O	23	NMOD	-1
17	,	,	I-NP	,	O	23	P	-1
18	-5	-5	I-NP	CD	O	23	NMOD	-1
19	,	,	I-NP	,	O	23	P	-1
20	-7	-7	I-NP	CD	O	23	NMOD	-1
21	,	,	O	,	O	23	P	-1
22	and	and	O	CC	O	23	NMOD	-1
23	-8	-8	B-NP	CD	O	11	SBAR	-1
24	.	.	O	.	O	5	P	-1

1	Immunocytochemistry	Immunocytochemistry	B-NP	NN	O	2	SUB	-1
2	revealed	reveal	B-VP	VBD	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	endosialin	endosialin	B-NP	NN	B-protein	5	SUB	-1
5	was	be	B-VP	VBD	O	3	SBAR	-1
6	present	present	B-ADJP	JJ	O	5	PRD	14	present
7	in	in	B-PP	IN	O	6	AMOD	-1
8	the	the	B-NP	DT	O	10	NMOD	-1
9	cytoplasmic	cytoplasmic	I-NP	JJ	O	10	NMOD	-1
10	body	body	I-NP	NN	O	7	PMOD	-1
11	and	and	B-PP	CC	O	7	PMOD	-1
12	in	in	B-PP	IN	O	7	PMOD	-1
13	the	the	B-NP	DT	O	15	NMOD	-1
14	elongated	elongate	I-NP	VBN	O	15	NMOD	0
15	extensions	extension	I-NP	NNS	O	12	PMOD	-1
16	essential	essential	B-ADJP	JJ	O	15	NMOD	0
17	to	to	B-PP	TO	O	16	AMOD	-1
18	pericyte	pericyte	B-NP	NN	O	19	NMOD	-1
19	function	function	I-NP	NN	O	17	PMOD	-1
20	.	.	O	.	O	2	P	-1

1	Transgenic	Transgenic	B-NP	JJ	O	2	NMOD	19	Transgenic
2	mice	mouse	I-NP	NNS	O	13	SUB	-1
3	engineered	engineer	B-VP	VBN	O	2	NMOD	-1
4	to	to	B-VP	TO	O	5	VMOD	-1
5	express	express	I-VP	VB	O	3	VMOD	9	express
6	human	human	B-NP	JJ	B-protein	7	NMOD	-1
7	endosialin	endosialin	I-NP	NN	I-protein	5	OBJ	-1
8	bred	breed	B-VP	VBN	O	7	NMOD	-1
9	on	on	B-PP	IN	O	8	VMOD	-1
10	an	an	B-NP	DT	O	12	NMOD	-1
11	immunocompromised	immunocompromised	I-NP	JJ	O	12	NMOD	-1
12	background	background	I-NP	NN	O	9	PMOD	-1
13	allowed	allow	B-VP	VBD	O	0	ROOT	-1
14	the	the	B-NP	DT	O	15	NMOD	-1
15	growth	growth	I-NP	NN	O	13	OBJ	4	growth
16	of	of	B-PP	IN	O	15	NMOD	-1
17	human	human	B-NP	JJ	O	19	NMOD	-1
18	tumor	tumor	I-NP	NN	O	19	NMOD	-1
19	xenografts	xenograft	I-NP	NNS	O	16	PMOD	-1
20	.	.	O	.	O	13	P	-1

1	In	In	B-PP	IN	O	17	VMOD	-1
2	human	human	B-NP	JJ	O	8	NMOD	-1
3	colon	colon	I-NP	NN	O	5	NMOD	-1
4	carcinoma	carcinoma	I-NP	NN	O	5	NMOD	-1
5	Colo205	Colo205	I-NP	NN	O	8	NMOD	-1
6	and	and	I-NP	CC	O	8	NMOD	-1
7	HT29	HT29	I-NP	NN	O	8	NMOD	-1
8	xenografts	xenograft	I-NP	NNS	O	1	PMOD	-1
9	grown	grow	B-VP	VBN	O	8	NMOD	4	grown
10	in	in	B-PP	IN	O	9	VMOD	-1
11	human	human	B-NP	JJ	O	13	NMOD	-1
12	endosialin-transgenic	endosialin-transgenic	I-NP	JJ	O	13	NMOD	19	transgenic
13	mice	mouse	I-NP	NNS	O	10	PMOD	-1
14	,	,	O	,	O	17	P	-1
15	endosialin	endosialin	B-NP	NN	O	16	NMOD	-1
16	expression	expression	I-NP	NN	O	17	SUB	9	expression
17	was	be	B-VP	VBD	O	0	ROOT	-1
18	largely	largely	I-VP	RB	O	17	VMOD	-1
19	confined	confine	I-VP	VBN	O	17	VC	-1
20	to	to	B-PP	TO	O	19	VMOD	-1
21	NG2-expressing	NG2-expressing	B-NP	JJ	B-cell_type	23	NMOD	9	expressing
22	perivascular	perivascular	I-NP	JJ	I-cell_type	23	NMOD	-1
23	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	-1
24	and	and	O	CC	O	19	VMOD	-1
25	not	not	B-NP	RB	O	19	VMOD	-1
26	CD31-positive	CD31-positive	I-NP	JJ	B-cell_type	28	NMOD	9	positive
27	endothelial	endothelial	I-NP	JJ	I-cell_type	28	NMOD	-1
28	cells	cell	I-NP	NNS	I-cell_type	25	PMOD	-1
29	.	.	O	.	O	17	P	-1

1	Similar	Similar	B-NP	JJ	O	2	NMOD	-1
2	methods	method	I-NP	NNS	O	10	SUB	-1
3	applied	apply	B-VP	VBN	O	2	NMOD	-1
4	to	to	B-PP	TO	O	3	VMOD	-1
5	human	human	B-NP	JJ	O	9	NMOD	-1
6	ovarian	ovarian	I-NP	JJ	O	9	NMOD	-1
7	and	and	I-NP	CC	O	9	NMOD	-1
8	colon	colon	I-NP	NN	O	9	NMOD	-1
9	tumors	tumor	I-NP	NNS	O	4	PMOD	-1
10	confirmed	confirm	B-VP	VBD	O	0	ROOT	-1
11	endosialin	endosialin	B-NP	NN	O	12	NMOD	-1
12	expression	expression	I-NP	NN	O	10	OBJ	9	expression
13	by	by	B-PP	IN	O	10	VMOD	-1
14	pericytes	pericyte	B-NP	NNS	B-cell_type	13	PMOD	-1
15	.	.	O	.	O	10	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	data	datum	I-NP	NNS	O	3	SUB	-1
3	indicate	indicate	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	endosialin	endosialin	B-NP	NN	B-protein	6	SUB	-1
6	is	be	B-VP	VBZ	O	4	SBAR	-1
7	strongly	strongly	I-VP	RB	O	6	VMOD	-1
8	expressed	express	I-VP	VBN	O	6	VC	9	expressed
9	by	by	B-PP	IN	O	8	VMOD	-1
10	pericytes	pericyte	B-NP	NNS	B-cell_type	9	PMOD	-1
11	during	during	B-PP	IN	O	8	VMOD	-1
12	periods	period	B-NP	NNS	O	11	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	active	active	B-NP	JJ	O	15	NMOD	-1
15	angiogenesis	angiogenesis	I-NP	NN	O	13	PMOD	3	angiogenesis
16	during	during	B-PP	IN	O	8	VMOD	-1
17	embryonic	embryonic	B-NP	JJ	O	20	NMOD	-1
18	and	and	I-NP	CC	O	20	NMOD	-1
19	tumor	tumor	I-NP	NN	O	20	NMOD	-1
20	development	development	I-NP	NN	O	16	PMOD	2	development
21	.	.	O	.	O	3	P	-1

1	Anti-endosialin	Anti-endosialin	B-NP	JJ	B-protein	2	NMOD	-1
2	antibodies	antibody	I-NP	NNS	I-protein	3	SUB	-1
3	may	may	B-VP	MD	O	0	ROOT	-1
4	have	have	I-VP	VB	O	3	VC	-1
5	value	value	B-NP	NN	O	4	OBJ	-1
6	in	in	B-PP	IN	O	4	VMOD	-1
7	identifying	identify	B-VP	VBG	O	6	PMOD	-1
8	vasculature	vasculature	B-NP	NN	O	7	OBJ	-1
9	in	in	B-PP	IN	O	8	NMOD	-1
10	malignant	malignant	B-NP	JJ	O	11	NMOD	-1
11	tissues	tissue	I-NP	NNS	O	9	PMOD	-1
12	.	.	O	.	O	3	P	-1

1	With	With	B-PP	IN	O	8	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	appropriate	appropriate	I-NP	JJ	O	4	NMOD	-1
4	agent	agent	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	8	P	-1
6	targeting	target	B-VP	VBG	O	8	SUB	19	targeting
7	endosialin	endosialin	B-NP	NN	O	6	OBJ	-1
8	may	may	B-VP	MD	O	0	ROOT	-1
9	interfere	interfere	I-VP	VB	O	8	VC	18	interfere
10	with	with	B-PP	IN	O	9	VMOD	-1
11	blood	blood	B-NP	NN	O	13	NMOD	-1
12	vessel	vessel	I-NP	NN	O	13	NMOD	-1
13	growth	growth	I-NP	NN	O	10	PMOD	4	growth
14	during	during	B-PP	IN	O	9	VMOD	-1
15	tumor	tumor	B-NP	NN	O	16	NMOD	-1
16	development	development	I-NP	NN	O	14	PMOD	2	development
17	.	.	O	.	O	8	P	-1

